The action of noncompetitive blockers of
glutamate receptors has been investigated on Krushinski-Molodkina rats genetically-prone to audiogenic
seizures. The selective blockers of
NMDA receptor channels,
memantine and
IEM-1921, and their dicationic homologues,
IEM-1925 and
IEM-1754, capable of blocking in varying degrees both
NMDA and Ca-permeable
AMPA receptor channels, were studied. The drugs were injected intramuscularly to rats with the different time intervals (30 min, 1, 2 or 3 hours) before sound signal. The effects of the drugs on latent period of initial locomotor activity provoked by audio stimulation (8 kHz sine-wave tone, 90 dB volume), the appearance of clonic convulsions of different intensities, and, finally, tonic convulsions with limb and tail extension were evaluated. Within 30 min after injection
IEM-1921 at a dose of 5 mg/kg, 33% of rats manifested a complete absence of convulsive reactions to sound, and in 59% of rats audiogenic
seizures occured only in the form of motor excitation without a generalized clonic-tonic convulsions.
Memantine at a dose of 5 mg/kg did not cause a complete blockade of
seizures, but after 1 h of injection in 50% of the rats and after 2 h in 70% of rats a weakening of the audiogenic
seizures to the level of motor excitation only was observed. After 3 hrs after administration of blockers its anticonvulsive action weakened significantly (p < 0.01). Dicationic blockers that block both
NMDA and
AMPA/
kainate receptors,
IEM-1925 (in doses of 0.001-20.0 mg/kg) and
IEM-1754 (0.025-50.0 mg/kg), did not affect audiogenic clonic-tonic convulsive reactions. The involvement of activation of
NMDA and
calcium permeable
AMPA/
kainate receptors in the pathogenesis of audiogenic
seizures is discussed.